Nextec BioSciences and council combine to foster biotech
06 June, 2002 by Tanya HollisInvestment banking group Nextec BioSciences has joined forces with the Melbourne City Council to establish an entrepreneurial incubator for biobusinesses.
BioStart kicks off with Mimetica
06 June, 2002 by Pete YoungThe first investment in a young biotech company has been made by the $6 million BioStart pre-seed fund set up a year ago by the Queensland government.
Rights issue to fund Analytica's new biotech strategy
06 June, 2002 by Pete YoungA $1.3 million rights issue by Analytica Ltd will test investor attitudes toward young biotechs who ask shareholders for a second chance after crashing on the first attempt.
Public gets a say on research focus
05 June, 2002 by Iain ScottThe Commonwealth government is hosting nationwide forums to help it set research priorities.
GTG sells Victorian mining assets
05 June, 2002 by Melissa TrudingerGenetic Technologies (ASX: GTG) has severed more of its ties with its former life as gold mining and exploration company Duketon Goldfields by offloading its remaining Victorian mining assets.
Bridges to retire from Panbio
05 June, 2002 by Melissa TrudingerQueensland-based diagnostics company Panbio has announced that CEO and co-founder Mel Bridges will retire in early 2003.
O'Brien Institute in analysis deal with UK biotech
04 June, 2002 by Tanya HollisA $1 million deal to analyse molecular changes in tumours has been signed between Melbourne's Bernard O'Brien Institute of Microsurgery (BOBIM) and a private London biotech.
HPLC market report: Cents and sensitivity
04 June, 2002 by Melissa TrudingerEase of use, reliability and service and support are the main things that scientists consider when buying a new chromatography system. But previous familiarity with a particular brand is also a major factor.
Billionare buys Amrad stake
04 June, 2002 by Tanya HollisIn a much-needed show of investor support, cardboard king Richard Pratt has become a substantial shareholder of Amrad Corporation.
New Zealand joins synchrotron project
03 June, 2002 by Tanya HollisA New Zealand representative is to join the Australian Synchrotron Project's scientific advisory committee, cementing a trans-Tasman link between users of the new facility.
CEO, directors depart as Bio21 changes direction
03 June, 2002 by Tanya HollisThe chief executive officer and three other directors have resigned from Bio21 following a restructure that has seen the company abandon its commercial focus.
Signs of new life at Vita Life
31 May, 2002 by Tanya HollisTroubled biopharmaceutical group Vita Life Sciences has warned shareholders not to expect much from the natural medicines arm of its business in the coming year.
Academy admits ARC head Sara
31 May, 2002 by Daniella GoldbergAustralian Research Council CEO Prof Vicki Sara has been admitted by special election as a fellow of the Australian Academy of Science, for her contribution to recent government reforms and initiatives.
Biotech stocks will keep falling... but not too far
30 May, 2002 by Daniella GoldbergAustralian biotechnology companies may be heading for a further tumble, delegates at the Financing Biotechnology meeting in Sydney this week were told.
Prana aims for Nasdaq
29 May, 2002 by Pete YoungPrana Biotechnology is following up recent successful Phase II clinical trials of its therapy for age-related diseases such as Alzheimer's with a bid to list on the US Nasdaq.
